Role of APE1 in differentiated neuroblastoma SH-SY5Y cells in response to oxidative stress; Use of APE1 small molecule inhibitors to delineate APE1 functions by Jiang, Yanlin et al.
Role of APE1 in differentiated neuroblastoma SH-SY5Y cells in
response to oxidative stress; Use of APE1 small molecule
inhibitors to delineate APE1 functions
Yanlin Jiang1, Chunlu Guo3, Melissa L. Fishel1, Zheng-Yu Wang3, Michael R. Vasko3, and
Mark R. Kelley1,2,3,4
1Department of Pediatrics (Section of Hematology/Oncology), Herman B Wells Center for Pediatric
Research, Indiana University School of Medicine, 1044 W. Walnut, Room 302C, Indianapolis, IN
46202
2Department of Biochemistry & Molecular Biology, Indiana University School of Medicine, 1044 W.
Walnut, Room 302C, Indianapolis, IN 46202
3Department of Pharmacology & Toxicology, Indiana University School of Medicine, 1044 W.
Walnut, Room 302C, Indianapolis, IN 46202
Abstract
Oxidative DNA damage has been implicated in a number of central nervous system pathologies. The
base excision repair (BER) pathway is one of the most important cellular protection mechanisms that
respond to oxidative DNA damage. Human apurinic (apyrimidinic) endonuclease/redox effector
factor (APE1/Ref-1 or APE1) is an essential enzyme in the BER pathway and is expressed in both
mitotic and post-mitotic cells in humans. In neurons, a reduction of APE1 expression increases
chemotherapy-induced cytotoxicity, while overexpression of APE1 protects cells against the
cytotoxicity. However, given the multiple functions of APE1, knockdown of total APE1 is not
completely informative of whether it is the redox or DNA repair activity, or interactions with other
proteins. Therefore, the use of selective small molecules that can block each function independent
of the other is of great benefit in ascertaining APE1 function in post-mitotic cells. In this study, we
chose differentiated SH-SY5Y cells as our post-mitotic cell line model to investigate whether a drug-
induced decrease in APE1 DNA repair or redox activity contributes to the growth and survival of
post-mitotic cells under oxidative DNA damaging conditions. Here, we demonstrate that
overexpression of WT-APE1 or C65-APE1 (repair competent) results in significant increase in cell
viability after exposure to H2O2. However, the 177/226-APE1 (repair deficient) did not show a
protective effect. This phenomenon was further confirmed by the use of methoxyamine (MX), which
blocks the repair activity of APE1 that results in enhanced cell killing and apoptosis in differentiated
SH-SY5Y cells and in neuronal cultures after oxidative DNA damaging treatments. Blocking APE1
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redox function by a small molecule inhibitor, BQP did not decrease viability of SH-SY5Y cells or
neuronal cultures following oxidative DNA damaging treatments. Our results demonstrate that the
DNA repair function of APE1 contributes to the survival of nondividing post-mitotic cells following
oxidative DNA damage.
Keywords
Base excision repair (BER); oxidative stress; APE1/Ref-1; small molecule inhibitors; post-mitotic
cells
1. Introduction
A number of environmental agents or metabolites induce neuronal damage through oxidative
stress [1–3] that occurs secondary to the generation of reactive oxygen species (ROS) in the
central nervous system (CNS). This can result in permanent damage given that the brain is
especially vulnerable to ROS [4] and since neurons do not readily regenerate [5]. Oxidative
stress is increasingly being implicated as an important causative agent in neuronal degenerative
diseases such as amyotrophic lateral sclerosis (ALS), Parkinson’s disease (PD) and
Alzheimer’s disease (AD) [6,7] as well as in aging. Recent data also have implicated oxidative
stress and DNA damage in peripheral neuropathy and cognitive dysfunction that follows
chemotherapy and ionizing radiation (IR) treatments of cancer patients [8,9].
The base excision repair (BER) pathway is one of the most important cellular protection
mechanisms that responds to oxidative DNA damage, having a more prominent role in
nondividing tissue [1]. The BER pathway including human apurinic (apyrimidinic)
endonuclease/redox effector factor (APE1/Ref-1 or APE1) is required for repair of single-base
modifications in DNA caused by ROS or spontaneous depurinations [1]. Removal of the
damaged base by a DNA glycosylase creates an apurinic/apyrimidinic (AP) site. The
endonuclease, APE1, a critical component in this pathway, hydrolyzes the phosphodiester
backbone 5’ to the AP site. Failure to repair AP sites or impairing the function of APE1 leads
to DNA strand breaks, enhanced oxidative stress-induced cytotoxicity, and increased apoptosis
[10]. In addition to its DNA repair function, APE1 also acts as a reduction-oxidation (redox)
factor for a variety of downstream transcription factors which impact upon a number of varied
signaling pathways including those involved in neuronal function and survival [1].
Since the early 1990s, many studies have highlighted APE1’s multiple functions, the
complexity of studying its multiple functions, and the importance of regulating APE1 activity
[11]. APE1 has received growing attention in neuronal and cardiovascular physiology and
pathophysiology in recent years [11]. Several laboratories, including ours, have demonstrated
that overexpression of APE1 protects cells against chemotherapeutic agents [1]. Previous work
from our laboratory has demonstrated that APE1 promotes survival of rat hippocampal and
sensory neuronal cells after exposed to H2O2 and cisplatin [8,9], primarily through studies
overexpressing or reducing expression of APE1. The question remains, however, whether the
neuroprotective effects of APE1 in post-mitotic cells are due to its ability to repair DNA or its
ability to alter the oxidative state of other molecules, or both. To address this question, we
chose to examine the effects of APE1 mutants that have only repair or only redox function on
oxidative stress-induced cytotoxicity and apoptosis in the SH-SY5Y cell line. These cells are
derived from a neural crest tumor of early childhood, predominantly composed of
undifferentiated neuroblast-like cells. Because these cells can be differentiated by exposure to
retinoic acid (RA) [12,13], we chose these cells as our model system to study the post-mitotic
phenotype. To delineate which function of APE1 was critical in the response to oxidative
damage, we overexpressed wild type APE1 (WT-APE1), redox deficient/repair competent
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APE1 (C65-APE1), and repair deficient/redox competent APE1 (177/226-APE1) in
differentiated SH-SY5Y cells. The cysteine at position 65 is required for full redox function
of APE1 [14]. The redox deficient APE1 contains an alanine at position 65, and can no longer
stimulate transactivation of a number of downstream targets such as nuclear factor-κB (NF-
κB) or AP-1, and others [3]. The repair deficient APE1 used in these experiments contains two
amino acid substitutions: R177A and N226A. This double mutant has dramatically decreased
endonuclease activity and decreased binding to damaged DNA [15]. However, in this study,
we also used for the first time, specific small molecule APE1 DNA repair inhibitor (MX) or a
redox inhibitor (BQP) as another means of manipulating the various functions of APE1. In this
report, we demonstrate using both genetic manipulation and small molecules that the DNA
repair function of APE1 and not its redox activity is critical for post-mitotic cell survival and
function.
2. Materials and methods
2.1. Cell culture
SH-SY5Y human neuroblastoma cells were obtained from ATCC (Manassas, VA), and were
cultured in Dulbecco’s MEM/Ham’s F12 medium (1:1 mixture, ATCC) supplemented with
10% heat-inactivated fetal calf serum and 100U/ml penicillin and 100ug/ml streptomycin in a
humidified 5% CO2, 95% air incubator at 37°C. The medium was changed every other day.
To induce differentiation, the cells were treated with 10µM All trans-retinoic acid (RA) in the
dark as described previously [12]. Adult rat dorsal root ganglion (DRG) and hippocampal cell
cultures were prepared as previously described [9,16].
2.2. Drugs
All trans-retinoic acid (RA), hydrogen peroxide (H2O2), 2-methyl-1,4-naphthoquinone
(menadione), hypoxanthine (HX), xanthine oxidase (XO), and methoxyamine hydrochloride
(MX) were purchased from Sigma (St. Louis, MO). 3-[5-(2,3-dimethoxy-6-methyl-1,4-
benzoquinoyl)]-2-nonyl-2-propionic acid (BQP) was custom synthesized [3]. MX was
dissolved in PBS, and stored as a 1mol/L stock at −20°C for 1 month. BQP was dissolved in
pure ethanol, stored as a 40mmol/L stock at −80°C for 2 weeks. Hypoxanthine (HX) was
dissolved in 1M NaOH, with the stock solution being 25mg/ml by adjusting the solution pH
to 7.4 using HCl. RA was prepared fresh with pure ethanol as a 10mmol/L, and then diluted
to 10µM with culture medium; menadione was prepared fresh with culture medium before use.
All stock solutions were appropriated diluted with buffer prior to use.
2.3. Adenoviral infection
Differentiated SH-SY5Y cells were infected with either the wild type Ad5 HA-APE1-IRES2-
EGFP (WT-APE1), the redox deficient/DNA repair competent Ad5 HA-C65A-IRES2-EGFP
(C65-APE1), DNA repair deficient/redox competent Ad5 HA-R177A + N226A-IRES2-EGFP
(177/226-APE1), or vector control Ad5 IRES2-EGFP (Vector) adenovirus at 25 plaque-
forming unitper cell for 24hrs by adding the virus directly to the growth medium, as previously
described [8,9]. An HA tag was added to the amino terminus of APE1 and APE1 mutants to
distinguish exogenous transgene overexpression from endogenous APE1 protein levels. After
24hrs, the medium containing adenovirus was aspirated and replaced with culture medium.
Infection efficiencies of transduced cells were determined using fluorescence microscopy
(Nikon, Tokyo, Japan) by measuring enhanced green fluorescent protein expression levels and
Western blotting to detect APE1 and HA-tagged proteins.
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2.4. Cell viability assay
Trypan blue exclusion analysis was performed as previously described [9]. Briefly, cells were
detached from the plate using a 0.05% trypsin-EDTA solution and media was added. Equal
volumes of the cell suspension and 0.4% (w/v) trypan blue in PBS were mixed, and the cells
were scored under phase contrast microscope using a hemacytometer. Percent survival was
calculated as percent of live cells divided by total cell number (including dead and live cells).
2.5. 3-(4-5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium salt (MTS) assay
Cell viability was also measured using the MTS assay (Celltiter 96 Aqueous One solution cell
proliferation assay, Promega Corp., Madison, WI) on differentiated SH-SY5Y cells grown in
96-well plates. Briefly, 24hrs after various drug treatments, the MTS solution was added to
each well and the plates were incubated for 4hrs. The absorbance at 490nm was measured using
a multiwell plate reader. The values were standardized to wells containing media alone.
2.6. Cell apoptosis analysis
Flow cytometric detection of apoptosis was performed using the Annexin V Apoptosis
Detection kit (BD Biosciences, Rockville, MD) according to manufacturer's instructions. Cells
were harvested using Trypsin-EDTA (Invitrogen Corp., Carlsbad, California). After washing
twice with PBS, the cells were resuspended in 100µl binding buffer and stained with Annexin
V-FITC/propidium iodide (PI). The cell suspension was incubated for 15min in the dark at 4°
C. The percentage of cells undergoing apoptosis was determined using flow cytometry.
Apoptotic cells were defined as those positive for Annexin V.
2.7. Western blot analysis
Western blots were performed as described previously [8,17]. Briefly, protein was quantified
and electrophoresed in a 12% SDS-polyacrylamide gel. After electrophoresis, the gel was
transferred to a nitrocellulose membrane. The membranes were separately incubated with a
primary antibody against GAP-43 (Novus Biologicals, Inc., Littleton, CO), APE1 [8,9], HA
(Roche Diagnostics Corp., Indianapolis, IN) and β-Actin (NeoMarkers, Inc., Fremont, CA).
Antibody binding was detected following appropriate secondary antibody using
chemiluminescence (Roche Diagnostics Corp., Indianapolis, IN), and equal loading was
confirmed by probing with β-Actin monoclonal antibody.
2.8. qRT-PCR assay
qRT-PCR was used to measure the mRNA expression levels of TNF-α (tumor necrosis factor-
alpha) gene. Adult sensory neuronal cultures were pretreated with or without 10 or 20µM BQP
3 days, then treated with 1mM H2O2 1h, then total RNA was extracted from cells following
1h and 5hrs culture using the combination of Qiagen QiaShredder kit and Qiagen RNeasy Mini
kit (Valencia, CA) according to the manufacturer's instructions. The extracted RNA was
quantified by a SmartSpec spectrophotometer (Bio-Rad Laboratories, Hercules, CA, USA) at
a wavelength of 260 nm. cDNA was synthesized by High-Capacity cDNA Reverse
Transcription Kit according to the protocol provided by the manufacture (Part No.: 4368814
Applied Biosystems). The primers for TNF-α were 5’-AGGCTGCCCCGACTATGTG-3’ and
5’-AGGAGGCTGACTTTCTCCTGGTA-3’; the primers for GAPDH were 5’-
GTATGACTCTAC CCACGGCAAGT-3’ and 5’-TCTCGCTCCTGGAAGATGGT-3’. qRT-
PCR was conducted on an ABI PRISM 7500 Sequence Detection System (Applied Biosystems)
using RT2-SYBR Green /ROX qPCR Master Mix (SABiosciences, Frederick, MD) in a 25ul
final reaction mixture. The cycling conditions were an incubation at 50°C for 2 min, 95°C for
10min and 40 cycls of 15s at 95°C, and 1 min at 60°C. Experiments were performed in triplicate
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for each sample. TNF-α was normalized to GAPDH, fold difference calculated by 2−ΔΔCt as
described before [18].
2.9. Statistical analysis
Quantitative data were obtained from three independent experiments and expressed as the mean
+/− SD. Statistical significances of differences between two groups were determined by using
Student’s t test. Statistical significance was taken as p<0.05 in all experiments.
3. Results
3.1. Post-mitotic cell line model: differentiated SH-SY5Y cells
SH-SY5Y cells differentiate into a post-mitotic phenotype after exposure to retinoic acid
[19,20]. To characterize the effects of RA on differentiation of SH-SY5Y cells, cells were
treated with 10µM RA, changed every two days and the RA was removed after 6 days of
treatment. During the time course, cell morphology was observed, cells were counted and
expression of GAP-43 was examined on various days during and after treatment. GAP-43
expression was used as a marker of differentiation since it is expressed by developing and
regenerating neurons [1] and its levels are highest during periods of neurite outgrowth [21].
RA treatment resulted in differentiation of SH-SY5Y cells, >90% of the cells displaying long
neurites on day 8 (Fig. 1A). Proliferation of the SH-SY5Y cells was dramatically decreased
following treatment with RA, as expected (Fig. 1B). There also was a dramatic increase in
GAP-43 expression following RA treatment for six days (Fig. 1C, upper panel). Both 10µM
and 20µM RA induced expression of GAP-43 by day 6. In addition, 10µM RA induced
expression of GAP-43 over time (days 4 – 8) (Fig. 1C, bottom panel). Based on these results
and previous publications [12,20], in all further experiments, we examined post-mitotic SH-
SY5Y cells 8 days after initiating RA treatment at 10µM.
3.2. Effect of APE1 overexpression on viability of differentiated SH-SY5Y following H2O2
treatment
Previous studies in our laboratory have demonstrated that a reduction in APE1 expression in
central and peripheral neurons increases cytotoxicity, while overexpression of APE1 decreases
cytotoxicity following treatment with both laboratory and chemotherapeutic agents that
produce oxidative stress [8,9]. To ascertain whether overexpression of APE1 effects survival
of differentiated SH-SY5Y cells, we infected the cells with HA tagged WT-APE1, C65-APE1,
177/226-APE1 or vector control adenoviral constructs containing an IRES site, and EGFP.
Adenovirus infection efficiency was determined using fluorescence microscopy with over 80%
of the cells showing green fluorescence after 48hrs exposure to virus (Fig. 2A). APE1
overexpression was confirmed using western blot analysis with HA or APE1 antibodies to
distinguish endogenous and transgene APE1 protein levels. As can be seen in representative
western blot (Fig. 2B), APE1 levels were significantly increased over endogenous levels in
cells infected with WT-APE1 and the two mutant APE1s. To ascertain whether overexpression
of WT-APE1 or APE1 mutants protect differentiated SH-SY5Y cells, the infected cells
expressing WT-APE1, C65-APE1, 177/226-APE1 or vector control were treated with 100µM
H2O2 for 24hrs, and cell viability was measured using trypan blue exclusion. As observed in
Fig. 2C, overexpression of WT-APE1 and C65-APE1 rescued differentiated SH-SY5Y cells
from cell killing by H2O2. In contrast, overexpression of the repair deficient 177/226-APE1
did not provide any protective effect (Fig. 2C). Since the C65-APE1 mutant has DNA repair
but not redox activity and the 177/226-APE1 has decreased DNA repair activity [15], these
results suggest that the repair, but not the redox function of APE1 is necessary for protection
against H2O2-induced cell death in post-mitotic SH-SY5Y cells.
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3.3. Effect of MX on cytotoxicity induced by agents producing oxidative DNA damage in the
differentiated SH-SY5Y cells, or DRG and hippocampal neuronal cultures
In view of the fact that APE1 has multiple functions and interacts with many other proteins
[1], the overexpression of APE1 protein may result in multiple effects, thereby making it
difficult to ascertain which of the functions of APE1 result in protection [3,22]. Consequently
to further substantiate that the repair function of APE1 is important in protecting post-mitotic
cells, we used MX to modify and stabilize the AP site, block the ability of APE1 to cut the
sugar-phosphate backbone, and thus prevent the completion of the repair process [23,24]. To
determine whether APE1 repair activity was linked to loss in cell viability, differentiated SH-
SY5Y cells were exposed to various concentrations of MX in the absence or presence of
oxidative stress and cell viability measured using the MTS assay. In cells treated with MX
alone, little to no reduction in cell viability was observed up to 100mM MX (Fig. 3A). As a
result, in subsequent studies, we used concentrations of MX up to 10mM. When differentiated
SH-SY5Y cells were exposed to MX in combination with increasing concentrations of
H2O2, MX enhanced H2O2-induced cell killing at all concentrations tested (Fig. 3B, left panel).
We also measured the effects of MX on cell killing induced by two additional compounds that
generate ROS, menadione and xanthine oxidase. Menadione, (2-methyl-1,4-naphthoquinone),
is a quinone compound that undergoes redox cycling and generates reactive oxygen species
[25,26]. Xanthine oxidase (XO) is an enzyme that catalyzes the sequential breakdown of
hypoxanthine (HX) to xanthine and subsequently to uric acid. In this oxidation process, XO
concomitantly generates several ROS by reducing molecular oxygen [27,28]. When cells were
exposed to increasing concentrations of menadione in the presence of MX, cell killing was
enhanced at concentrations of menadione greater than 30µM, albeit not as dramatically as
H2O2 or XO (Fig. 3B, middle panel). Similar to H2O2 and menadione, when APE1’s DNA
repair function was blocked by MX, there was a significant enhancement of XO/HX-induced
cell killing (Fig. 3B, right panel). The LD50 of H2O2 and XO/HX in the presence or absence
of MX treatment are shown in Table 1. The LD80 of menadione is included because the effect
of MX was more significant at the LD80. MX significantly decreased the LD50 or LD80 of the
three oxidizing agents compared to agent alone in a concentration-dependent manner.
However, the effect of MX with menadione, while statistically significant was not as dramatic.
To ascertain whether the cytotoxicity of primary neurons to oxidizing agents is enhanced when
the DNA repair activity of APE1 is blocked, we treated adult rat DRG cultures and adult rat
hippocampal cultures with various concentrations of H2O2 for 1hr in the presence or absence
of MX and assessed cellular viability using trypan blue exclusion at 24hrs. As observed in the
SH-SY5Y cells, MX enhanced H2O2-induced cytotoxicity in both neuronal cultures. The
enhanced cell killing induced by MX was MX concentration-dependent (Fig. 3C, D). The
LD50 of H2O2 +/− MX treatment in DRG and hippocampal neuronal are shown in Table 2.
3.4. MX increases apoptosis of differentiated SH-SY5Y cells induced by oxidative DNA
damaging agents
ROS are potent inducers of apoptosis [29]. To determine whether blocking the DNA repair
function of APE1 with MX affects oxidative stress-induced apoptosis in the differentiated SH-
SY5Y cells and confirm the cytotoxicity data in Fig. 3, we incubated the cells with either
H2O2, menadione or XO/HX in the absence or presence of MX for 24hrs. Apoptosis was
determined using Annexin V and propidium iodide (PI) staining. As shown in the representative
experiment in Fig. 4A, addition of MX to oxidative DNA damaging agents resulted in a
significant increase in Annexin V positive cells (lower and upper right quadrants) indicating
apoptotic cells. In three separate experiments, the addition of MX caused a 9% to 21% increase
in apoptosis induced by H2O2 treatment, a 12% to 23% increase in apoptosis induced by
menadione treatment, and an 18% to 44% increase in apoptotic cells in cultures treated with
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XO/HX (Fig. 4B). The addition of MX to H2O2, menadione, and XO/HX treatment
dramatically reduced cell survival both by killing and apoptosis-based assays.
3.5. Effect of BQP on cytotoxicity in differentiated SH-SY5Y cells induced by oxidative DNA
damaging agents
BQP is a specific, small molecule inhibitor of the redox function of APE1 that does not affect
its DNA repair function [3,30]. To further confirm that the redox function of APE1 was not as
critical following oxidative stress, we treated cells with oxidative DNA damaging agents in
combination with APE1 redox inhibitor, BQP. The MTS assay was used to evaluate cell
survival following increasing doses of BQP in the absence or presence of oxidative DNA
damaging agents. At BQP concentrations of 50µM or greater, cell survival was significantly
decreased in SH-SY5Y cells compared to vehicle control, with a resulting LD50 of 80µM (Fig.
5A). As noted in Fig. 5A, the viability of SH-SY5Y cells was not affected with BQP
concentrations of 25µM or less within 24hrs treatment. Blocking APE1’s redox function using
BQP at 15µM and 25µM did not significantly alter cytotoxicity induced by H2O2, menadione,
or XO/HX (Fig. 5B). To ascertain whether primary cultures of neuronal cells are responding
in a similar manner to differentiated SH-SY5Y cells, we treated rat DRG and hippocampal
cultures with H2O2 in the absence or presence of 10, 20 or 40µM BQP. In contrast to
differentiated SHSY5Y cells, BQP significantly reduced H2O2-induced cytotoxicity in DRG
or hippocampal neuronal cell cultures (Fig. 6A, B), suggesting it has a protective effect in these
cultures.
3.6. Effect of BQP on H2O2-induced TNF-α mRNA expression in DRG neuronal cell cultures
Some previous studies have demonstrated that BQP inhibits the production of TNF-α through
inhibition of NF-κB, a redox signaling target of APE1, at the transcriptional level [31–33].
TNF-α is also known to induce neuronal damage in mitochondrial respiration [34]. To ascertain
whether BQP protects DRG cell cultures against H2O2-induced cytotoxity through a NF-κB
mediated pathway producing TNF-α production, we pretreated DRG cell cultures with BQP
for 3 days. We then challenged the cells with 1mM H2O2 for 1hr and analyzed TNF-α mRNA
levels using qRT-PCR assay. We used DRG cells for these studies as we could not detect TNF-
α in the SH-SY5Y cells and they represent a more real life model. As predicted, 10µM and
20µM BQP significantly reduced H2O2-induced TNF-α mRNA expression in DRG cultures.
Using 10µM BQP, H2O2-induced TNF-α mRNA level was reduced 40% at the two and six
hour time points, while 20µM BQP, H2O2-induced TNF-α mRNA level was reduced 60% at
the two hour time point and and 80% at the six hour time point compared to no BQP vehicle
control (Fig. 7). Because inhibition of mRNA for TNF-α serves as a biomarker for NF-κB
production [31,32], these results suggest that inhibition of APE1’s redox function by BQP
contributed to the protective effect in neuronal cell cultures through APE1 down-regulated
activity of NF-κB and subsequent downstream events such as TNF-α reduction [33].
4. Discussion
Based on the results presented here, it is clear that the DNA repair function of APE1 is critical
for protection of post-mitotic cells against agents that produce oxidative DNA damage. The
SH-SY5Y cell line is derived from a neural crest tumor of early childhood, predominantly
composed of undifferentiated neuroblast-like cells. These neuroblastoma cells respond to
retinoic acid (RA) by differentiating into cells of neuronal, post-mitotic phenotype [19,35].
The SH-SY5Y system allows us to prepare large numbers of differentiated cells for use in our
neuronal studies [35] and to compare and contrast with studies in primary rat DRG and
hippocampal neuronal cell cultures. Overexpression of WT-APE1 in differentiated SH-SY5Y
cells protected cells from H2O2-induced cytotoxicity. This finding is analogous to our previous
work demonstrating that WT-APE1 is protective when overexpressed in neuronal cells grown
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in culture [8,9]. To further examine which function of APE1, DNA repair or redox provided
this protective effect, we overexpressed APE1 mutants in SH-SY5Y cells. The C65-APE1
mutant contains a mutation at the Cys at position 65 which abolishes APE1’s redox function
but does not affect its repair capability [3,14]. Overexpression of C65-APE1 provides the same
degree of protection as WT-APE1. In contrast, overexpression of the DNA repair deficient
mutant, 177/226-APE1, did not protect cells from H2O2-induced cell death.
We also used small molecule inhibitors of the DNA repair or redox function of APE1 to
ascertain which functions of APE1 are critical for neuroprotection. Exposing SH-SY5Y cells
to BQP, did not enhance cell death induced by oxidative DNA damage, whereas exposing
primary neuronal cultures to BQP reduced rather than enhanced cell death induced by H2O2.
Blocking APE1’s repair activity with MX reduced cell viability and increased apoptosis in
response to oxidative DNA damaging agents in differentiated SH-SY5Y cells and in primary
neuronal cultures. These results expand on our previous work in hippocampal and DRG cell
cultures showing that overexpression of APE1 is neuroprotective against H2O2 and cisplatin,
while reducing APE1 expression is neurotoxic [8,9]. In those studies, we surmised that in post-
mitotic neuronal cells, APE1’s DNA repair function was critical to survival. This notion was
based on overexpression of constructs containing similar to the ones described here. However
we could not completely rule out the redox component of APE1 since overexpression of C65-
APE1 provided partial protective effect in hippocampal and DRG cell cultures against H2O2
and cisplatin [8,9]. By using small molecule inhibitors of either the repair or redox function of
APE1 in the current study, we can conclude that the DNA repair function of APE1 is the critical
function in protecting post-mitotic cells against oxidative DNA damage. Previous studies have
reported that knocking down APE1 leads to cell death [10,36] and is most likely due to the
DNA repair function of APE1 rather than the redox activity [2,37–39]. Additionally, the role
of APE1’s redox and repair functions, as well as APE1’s protein-protein interactions may be
varied in post-mitotic cells, such as DRG cultures [9,17], as well as neuronal cell line models
such as the extensively used SH-SY5Y cells. However, the results presented in this manuscript
demonstrating that the DNA repair function of APE1 is important for cellular function and
survival in post-mitotic cells is a novel finding and supports our previous studies using
overexpression of APE1 repair or redox mutants. These findings also explain why inhibition
of APE1’s redox function had no effect on the survival of the post-mitotic cells under oxidative
DNA damaging conditions.
Our results implicating the DNA repair function of APE1 as crucial in the survival of post-
mitotic cells following oxidative stress is not overly surprising. In light of data demonstrating
that mice lacking APE1 are embryonic lethal and the need for adequate DNA repair early on
in development [40,41], it is clear that the DNA repair function is critical to the survival of
animals and, presumably, humans [2,3,17,22,30,42,43]. As a major member of the BER
pathway, APE1 acts on AP sites in DNA, which, if left unrepaired, can result in a block to
DNA replication, cytotoxicity, mutations, and genetic instability [22,44]. In embryonic
development robust DNA repair is required to sustain DNA integrity during accelerated DNA
transactions, which support rapid cell proliferation. However, knockdown or out studies
remove both the DNA repair and redox functions of APE1.
In previous studies to reveal whether APE1 was essential to normal and/or cancer cells [1–3,
8,17,22,30,38,39,42,43,45,46], antisense to APE1 or APE1 siRNA was utilized. These types
of experimental conditions remove not only the DNA repair function of APE1, but also its
redox function and all protein–protein interactions mediated by APE1 [22]. Thus, using
antisense RNA or similar technology, it is not possible to determine precisely the role of the
endonuclease or redox function of APE1 in cancer or normal cells without specific inhibitors
of each function independently. As demonstrated by the results presented here, the use of
specific small-molecule inhibitors such as MX and BQP allowed us to delineate the true role
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of APE1 in post-mitotic cells following oxidative stress [3,30]. Additional reports by others
also demonstrate that overexpression of APE1 inhibits superoxide and hydrogen peroxide
production [47] and that overexpression of APE1 in cells deficient for XRCC1 compensates
for the deficient single-strand break repair in these cells following oxidative DNA damage and
stress [48].
This is the first report using APE1 specific small molecule repair or redox inhibitors in a post-
mitotic system, differentiated SH-SY5Y cells, or in primary neuronal cells: rat DRG and
hippocampal cells. The APE1 repair inhibitor, MX, binds to AP sites in DNA and blocks the
ability of APE1 to incise the sugar-phosphate backbone and prevents the completion of the
repair process [22,23,49,50]. MX has previously been studied as a structural modulator of AP
sites that enhances the therapeutic effect of chemotherapeutic agents, such as temozolomide
(TMZ), through its ability to block the repair of AP sites [22,23,49,50]. Clinical trials with MX
in combination with TMZ are currently being pursued [17,23,30,38,42,50,51]. As shown in
Fig. 3 and Fig. 4, MX is not significantly cytotoxic by itself in post-mitotic cells, however
when APE1’s DNA repair function is blocked with MX, we demonstrate a dramatic
enhancement of oxidant-induced cytotoxicity and apoptosis in differentiated SH-SY5Y cells
and primary DRG and hippocampal neuronal cell cultures. Interestingly, the effect was most
dramatic when combining H2O2 and XO with MX and less so with menadione, although
statistically significant (Fig. 3). This could be explained by the fact that menadione is a redox-
cycling drug that creates large amounts of intracellular superoxide anions and lesser amounts
of H2O2 [29]. In the XO system, a significant amount of H2O2 is produced as well as hydroxyl
radicals which are both strong damagers of DNA [29]. Since menadione undergoes redox
cycling there is a more gradual increase in ROS levels [52,53]. This could explain the
differences between the results with agents that induce oxidative DNA damage in different
ways.
Since APE1 stimulates the transcriptional activity of numerous transcription factors that are
involved in a multitude of diverse physiological functions such as cell cycle control, apoptosis,
angiogenesis, cellular growth, cellular differentiation, neuronal excitation, hematopoiesis and
development through its redox function, it was possible that the redox function could be
important in post-mitotic cells [44]. Our data (Fig. 5), however, indicate that inhibition of
APE1’s redox function by BQP did not increase the killing effect of the oxidative damage
analyzed. In fact, when BQP was used on primary DRG and hippocampal neuronal cell cultures
in combination with H2O2, the cells were less sensitive to the effects of oxidative DNA damage
by H2O2. This supports our hypothesis that the redox role is independent of the APE1 DNA
repair function. The APE1 redox inhibitor, BQP, was initially identified as a small molecule
that inhibited TNF-α production in vivo [32,54] using hepatitis models and LPS-stimulated
macrophages including mononuclear cells and Kupffer cells. TNF-α is known to induce
apoptosis in neurodegenerative diseases [55]. Although the mechanism by which BQP is
protective in primary neuronal cultures remains unknown, our observations show that BQP
reduced H2O2-induecd TNF-α mRNA levels in primary rat DRG, providing a possible
mechanism by which the effect of BQP on TNF-α generation contributes to the neuroprotective
effect. BQP was also shown to suppress DNA-binding of NF-κB [56]. Therefore, although
BQP does not bind to NF-κB, but APE1, one possible explanation for its protective effect
observed in the presence of H2O2 is it blocks NF-κB function by blocking NF-κB’s ability to
bind to various promoter’s such as the TNF-α promoter and, therefore, reduce TNF-α
expression. Clearly, this is just one pathway that could be affected and additional experiments
are ongoing to determine additional pathways under APE1 redox control that could contribute
to our observed results.
The question remains whether APE1 repair function is critical in DNA repair in the nucleus or
in the mitochondria, or both. Thus, further studies are needed to determine the potential role
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of mitochondria, and specifically APE1 in mitochondria, in post-mitotic cells response to ROS.
APE1 has been demonstrated to function as a DNA repair enzyme in mitochondrial DNA repair
[17]. Given our findings that it is primarily the DNA repair and not the redox activity of APE1
that is important for post-mitotic cellular survival and response to oxidative DNA damage, the
role of APE1 in mitochondrial function is of great interest. These studies will lead us to new
avenues of research to determine if we can therapeutically block the effect of post-mitotic
cellular killing and dysfunction following cancer treatments in order to decrease the side-effects
that are often damaging and debilitating to the patients undergoing cancer treatments.
In summary, to our knowledge, this is the first report of using small molecule inhibitors of
APE1’s DNA repair or redox function and the consequences of such inhibition on nondividing,
post-mitotic cells. The use of small molecule APE1 redox or repair inhibitors confirms our
analyses using mutant redox or repair APE1 transgene overexpression studies. These studies
all conclude that the repair and not the redox function of APE1 is the most important activity
of APE1 following oxidative stress in post-mitotic cells as typified by SH-SY5Y differentiated
cells.
The abbreviations used are
APE1, human apurinic (apyrimidinic) endonuclease/redox effector factor
WTAPE1, wild type APE1
C65-APE1, repair competent/redox deficient APE1
177/226-APE1, repair deficient/redox competent APE1
MX, methoxyamine
BQP, 3-[5-(2,3-dimethoxy-6-methyl-1,4-benzoquinoyl)]-2-nonyl-2-propionic acid
HX, hypoxanthine
XO, xanthine oxidase
RA, retinoic acid
IR, ionizing radiation
ROS, reactive oxygen species
BER, base excision repair
DRG, dorsal root ganglion
ALS, amyotrophic lateral sclerosis
PD, Parkinson’s disease
AD, Alzheimer’s disease
HA, hemagglutinin epitope
EGFP, enhanced green fluorescent protein
IRES, internal ribosome entry sites
PI, propidium iodide
FITC, fluorescein isothiocyanate
TNF-α, tumor necrosis factor-alpha
NF-κB, nuclear factor-κB
TMZ, temozolomide
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